유전성 항트롬빈 결핍증이 동반된 만성 폐혈전색전성 폐동맥 고혈압 1예

A case of chronic thromboembolic pulmonary hypertension (CTEPH) with antithrombin III deficiency

  • 이미래 (성균관대학교 의과대학 삼성서울병원 내과) ;
  • 김미연 (성균관대학교 의과대학 삼성서울병원 내과) ;
  • 배선윤 (성균관대학교 의과대학 삼성서울병원 내과) ;
  • 정호중 (성균관대학교 의과대학 삼성서울병원 내과) ;
  • 박표원 (성균관대학교 의과대학 삼성서울병원 흉부외과) ;
  • 김희진 (성균관대학교 의과대학 삼성서울병원 진단검사의학과) ;
  • 김덕경 (성균관대학교 의과대학 삼성서울병원 내과)
  • Lee, Mi-Rae (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Mi-Yeon (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Bae, Sun-Youn (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Chung, Ho-Jung (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Pyo-Won (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Hee-Jin (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Duk-Kyung (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2009.10.04
  • 심사 : 2009.12.07
  • 발행 : 2010.12.01

초록

저자들은 유전자 검사로 확진된 유전성 항트롬빈 결핍증을 가진 39세 남자 환자에서 만성 폐혈전색전성 폐동맥고혈압이 발생하여 혈전내막제거술을 시행한 증례를 국내 최초로 보고하는 바이다. 환자는 내원 시 NYHA class III의 심한 호흡곤란을 보였다. 검사 결과 환자는 폐혈전색전증 및 우심실 부전을 동반한 심한 폐동맥 고혈압을 가진 것으로 진단되었다. 유전자 검사로 SERPINC1 유전자에 새로운 돌연변이가 있는 것이 확인되었다. 환자는 하대정맥 필터 삽입과 폐동맥 혈전내막제거술을 받았다. 이후 1년의 경과관찰 동안 환자는 NYHA class I의 상태를 유지하였고, 우심실 기능의 정상화를 보여주었다.

Presented is a case study of a 39-year-old man with chronic thromboembolic pulmonary hypertension (CTEPH) and an underlying antithrombin III (AT III) deficiency. The subject presented with severe dyspnea (NYHA functional class III). A diagnostic workup led to a diagnosis of pulmonary thromboembolism and severe pulmonary hypertension with right ventricular failure. Genetic analysis revealed a novel nonsense mutation (c.243G > A) in SERPINC1. Pulmonary thromboendarterectomy was performed following the insertion of an inferior vena cava filter. After one year, the subject remained in NYHA functional class I and exhibited normal right ventricular function. This is the first report of a genetically confirmed AT III deficiency complicated by CTEPH in Korea.

키워드

참고문헌

  1. Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 28:255-269, 2007 https://doi.org/10.1016/j.ccm.2006.11.009
  2. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257-2264, 2004 https://doi.org/10.1056/NEJMoa032274
  3. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293:2352-2361, 2005 https://doi.org/10.1001/jama.293.19.2352
  4. Yoshida M, Mukohara N, Obo H, Ozaki N, Shida T, Okita Y. Pulmonary thromboendarterectomy for chronic pulmonary thromboembolism in protein C deficiency. Jpn J Thorac Cardiovasc Surg 54:70-74, 2006
  5. Lim JY, Lee JW, Kim JW, Jung SH, Je HG, Song H, Chung CH, Choo SJ. Clinical results after pulmonary endarterectomy as a curative surgical method in chronic thromboembolic pulmonary hypertension: an approach to operative classification of thromboembolic disease. Korean J Thorac Cardiovasc Surg 41:591-597, 2008
  6. Jamieson SW, Nomura K. Indications for and the results of pulmonary thromboendarterectomy for thromboembolic pulmonary hypertension. Semin Vasc Surg 13:236-244, 2000
  7. Takahashi J, Ito M, Okude J, Gohda T, Wakamatsu Y, Sasaki S, Yasuda K. Pulmonary thromboembolectomy in congenital antithrombin III deficiency associated with acute pulmonary embolism: report of a case. Ann Thorac Cardiovasc Surg 9:192-196, 2003
  8. Laczika K, Lang IM, Quehenberger P, Mannhalter C, Muhm M, Klepetko W, Kyrle PA. Unilateral chronic thromboembolic pulmonary disease associated with combined inherited thrombophilia. Chest 121:286-289, 2002 https://doi.org/10.1378/chest.121.1.286
  9. Kim JC, Kang SY, Song HS, Lee SA. Cerebral venous sinus thrombosis associated with antithrombin III deficiency: a case report. J Korean Neurol Assoc 18:637-641, 2000
  10. Kim KY, Moon KW, Jeon DS, Choi JY, Jeon DH, Kim JW, Lee JS, Choi MS, Lee GH, Lee MY. A case of hereditary antithrombin III deficiency manifested by myocardial infarction and deep vein thrombosis. Korean Circ J 32:521-525, 2002 https://doi.org/10.4070/kcj.2002.32.6.521
  11. Eum MS, Park YH, Seol JI, Chae SY, You MB, Kang KH, Lee BS, Ha CE, Park JS, Jung YH, Ahn SH, Lee HJ. A case of combined deficiency of antithrombin III and protein C complicated by recurrent venous thrombosis. Korean J Med 62:570-574, 2002
  12. Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schonauer V, Exner M, Klepetko W, Kneussl MP, Maurer G, Lang I. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 93:512-516, 2005
  13. Rossi E, Za T, Ciminello A, Leone G, De Stefano V. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia. Thromb Haemost 99:1030-1034, 2008 https://doi.org/10.1160/TH08-02-0069